Evidence map›Paper›PMID 32150236›Full record

ArticleJAMA pediatrics2020

Association Between Rotavirus Vaccination and Type 1 Diabetes in Children.

Jason M Glanz, Christina L Clarke, Stanley Xu, Matthew F Daley, Jo Ann Shoup, Emily B Schroeder, Bruno J Lewin, David L McClure, Elyse Kharbanda, Nicola P Klein and 1 more

Open access · bronzeAbstract readVideo-Audio Media
In one paragraph

Article in JAMA pediatrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Advanced Delivery Strategies for Immunotherapy in Type I Diabetes Mellitus.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2023
    Review
  8. Review
  9. Article
  10. COVID-19 and diabetes in children.Annals of pediatric endocrinology & metabolism · 2022
    Article
  11. Review
  12. Review
  13. Global Experience With Rotavirus Vaccines.The Journal of infectious diseases · 2021
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Childhood Vaccinations and Type 1 Diabetes.Frontiers in immunology · 2021
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Jason M GlanzInstitute for Health Research, Kaiser Permanente Colorado, Aurora.
Christina L ClarkeInstitute for Health Research, Kaiser Permanente Colorado, Aurora.
Stanley XuInstitute for Health Research, Kaiser Permanente Colorado, Aurora.
Matthew F DaleyInstitute for Health Research, Kaiser Permanente Colorado, Aurora.
Jo Ann ShoupInstitute for Health Research, Kaiser Permanente Colorado, Aurora.
Emily B SchroederInstitute for Health Research, Kaiser Permanente Colorado, Aurora.
Bruno J LewinKaiser Permanente Department of Research and Evaluation, Kaiser Permanente of Southern California, Pasadena.
David L McClureMarshfield Clinic Research Institute, Marshfield Clinic Health System, Marshfield, Wisconsin.
Elyse KharbandaDivision of Research, HealthPartners Institute, Minneapolis, Minnesota.
Nicola P KleinKaiser Permanente Division of Research, Kaiser Permanente of Northern California, Oakland.
Frank DeStefanoImmunization Safety Office, Vaccine Safety Datalink, Centers for Disease Control and Prevention, Atlanta, Georgia.
Kaiser Permanente · USCenters for Disease Control and Prevention · USHealthPartners · USMarshfield Clinic · USParkview Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Because rotavirus infection is a hypothesized risk factor for type 1 diabetes, live attenuated rotavirus vaccination could increase or decrease the risk of type 1 diabetes in children. Objective: To examine whether there is an association between rotavirus vaccination and incidence of type 1 diabetes in children aged 8 months to 11 years. Design, Setting, and Participants: A retrospective cohort study of 386 937 children born between January 1, 2006, and December 31, 2014, was conducted in 7 US health care organizations of the Vaccine Safety Datalink. Eligible children were followed up until a diagnosis of type 1 diabetes, disenrollment, or December 31, 2017. Exposures: Rotavirus vaccination for children aged 2 to 8 months. Three exposure groups were created. The first group included children who received all recommended doses of rotavirus vaccine by 8 months of age (fully exposed to rotavirus vaccination). The second group had received some, but not all, recommended rotavirus vaccines (partially exposed to rotavirus vaccination). The third group did not receive any doses of rotavirus vaccines (unexposed to rotavirus vaccination). Main Outcomes and Measures: Incidence of type 1 diabetes among children aged 8 months to 11 years. Type 1 diabetes was identified by International Classification of Diseases codes: 250.x1, 250.x3, or E10.xx in the outpatient setting. Cox proportional hazards regression models were used to analyze time to type 1 diabetes incidence from 8 months to 11 years. Hazard ratios and 95% CIs were calculated. Models were adjusted for sex, race/ethnicity, birth year, mother's age, birth weight, gestational age, number of well-child visits, and Vaccine Safety Datalink site. Results: In a cohort of 386 937 children (51.1% boys and 41.9% non-Hispanic white), 360 169 (93.1%) were fully exposed to rotavirus vaccination, 15 765 (4.1%) were partially exposed to rotavirus vaccination, and 11 003 (2.8%) were unexposed to rotavirus vaccination. Children were followed up a median of 5.4 years (interquartile range, 3.8-7.8 years). The total person-time follow-up in the cohort was 2 253 879 years. There were 464 cases of type 1 diabetes in the cohort, with an incidence rate of 20.6 cases per 100 000 person-years. Compared with children unexposed to rotavirus vaccination, the adjusted hazard ratio was 1.03 (95% CI, 0.62-1.72) for children fully exposed to rotavirus vaccination and 1.50 (95% CI, 0.81-2.77) for children partially exposed to rotavirus vaccination. Conclusions and Relevance: The findings of this study suggest that rotavirus vaccination does not appear to be associated with type 1 diabetes in children.

Indexed as

ChildChild, PreschoolDiabetes Mellitus, Type 1FemaleFollow-Up StudiesHumansIncidenceInfantMaleRetrospective StudiesRotavirus VaccinesUnited StatesRotavirus Vaccines

Identifiers

PMID32150236
PMCPMC7063538
OpenAlexW3010068624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.